BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2839846)

  • 1. Simultaneous endocrine management and chemotherapy as initial treatment in M1 prostatic carcinoma.
    Richards B
    Prog Clin Biol Res; 1988; 269():177-86. PubMed ID: 2839846
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of newly diagnosed metastatic carcinoma of the prostate.
    Elder JS; Catalona WJ
    Urol Clin North Am; 1984 May; 11(2):283-95. PubMed ID: 6428022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a best endocrine management of prostatic carcinoma?
    Robinson MR
    Prog Clin Biol Res; 1988; 269():147-58. PubMed ID: 2969114
    [No Abstract]   [Full Text] [Related]  

  • 4. Early versus delayed endocrine treatment in metastatic prostatic cancer.
    Schröder FH
    Prog Clin Biol Res; 1989; 303():253-60. PubMed ID: 2674988
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of breast cancer with hormones and drugs.
    Lippman ME
    Hosp Pract (Off Ed); 1986 May; 21(5):119-27, 131. PubMed ID: 3009506
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients with advanced prostate cancer.
    Labrie F; Dupont A; Giguère M; Borsanyi JP; Lacourciere Y; Bélanger A; Lachance R; Emond J; Monfette G
    Prog Clin Biol Res; 1988; 260():41-62. PubMed ID: 3283766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lessons from phase III-trials on the hormonal treatment of prostatic cancer. I: Results of EORTC-trials 30761 and 30762.
    de Voogt HJ; Pavone-Macaluso M; Smith PH; de Pauw M; Suciu S
    Prog Clin Biol Res; 1988; 260():111-7. PubMed ID: 2966403
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemotherapy of hormonally unresponsive prostatic carcinoma.
    deKernion JB; Lindner A
    Urol Clin North Am; 1984 May; 11(2):319-26. PubMed ID: 6233779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen depletion/repletion in combination with chemotherapy: strategy for secondary treatment of metastatic prostatic cancer.
    Santen RJ; English H; Rohner T; Drago J; Lipton A; Harvey H; Simmonds M; Boucher A; Glode LM; Wettlaufer J
    Prog Clin Biol Res; 1985; 185A():359-71. PubMed ID: 4034580
    [No Abstract]   [Full Text] [Related]  

  • 10. [Advanced prostatic cancer: therapeutic modalities].
    Faul P; Altwein JE
    Dtsch Med Wochenschr; 1984 Dec; 109(51-52):1975-80. PubMed ID: 6391887
    [No Abstract]   [Full Text] [Related]  

  • 11. [Combination hormone-chemotherapy versus hormone therapy alone in the initial treatment of advanced prostate carcinoma--a prospective cooperative study].
    Gorski J; Böhm WD; Illig HD; Koch R
    Urologe A; 1988 Sep; 27(5):287-90. PubMed ID: 3051628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current management of prostatic carcinoma.
    Bahnson RR; Catalona WJ
    Prim Care; 1985 Dec; 12(4):795-813. PubMed ID: 3909178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant hormonal deprivation in locally advanced prostate cancer: does it make sense?
    Schulman CC; Wildschutz TP
    Acta Urol Belg; 1996 May; 64(2):57-61. PubMed ID: 8701814
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cellular immunity in prostatic cancer modified by Cytonal, Estrazyt and Turisteron].
    Klebingat KJ; Panzig E; Lorenz G; Steinhauser I; Fiedler R
    Z Urol Nephrol; 1987 Mar; 80(3):139-47. PubMed ID: 3300097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The case for early combined hormonal and cytostatic treatment for metastatic prostatic carcinoma.
    Servadio C
    Prog Clin Biol Res; 1987; 243B():449-53. PubMed ID: 3659039
    [No Abstract]   [Full Text] [Related]  

  • 16. Cancer of the prostate:estrogen therapy: natural conjugated estrogen vs. Stillbestrol: A point of view.
    Kaplan L
    Rev Surg; 1968; 25(5):323-9. PubMed ID: 4301296
    [No Abstract]   [Full Text] [Related]  

  • 17. [A case of giant prostate cancer].
    Fujimoto Y; Yamaha M; Maeda S; Takeuchi T; Ito Y; Kuriyama M; Ban Y; Nishiura T
    Hinyokika Kiyo; 1984 Jul; 30(7):925-30. PubMed ID: 6542303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Endocrine therapy for prostatic carcinoma--the clinical trial to compare the efficacy of LH-RH analogue, ICI 118630 (Zoladex) with castration or estrogen].
    Usami M; Kotake T; Matsuda M; Okajima E; Osafune M; Akaza H; Niijima T; Aso Y; Araki T; Itatani H
    Hinyokika Kiyo; 1988 Oct; 34(10):1853-63. PubMed ID: 2977527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of metastatic prostatic cancer.
    Paulson DF
    Urology; 1985 Feb; 25(2 Suppl):49-52. PubMed ID: 3918376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone therapy in cancer.
    Kennedy BJ
    Geriatrics; 1970 Oct; 25(10):106-12. PubMed ID: 4096937
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.